论文部分内容阅读
目的分析2012—2015年浙江省乐清市恶性肿瘤发病特征及流行趋势,为制定恶性肿瘤预防控制策略提供依据。方法对2012—2015年乐清市恶性肿瘤发病资料进行描述性流行病学分析。结果 2012—2015年乐清市恶性肿瘤年平均发病率为248.85/10万,年发病率分别为238.24/10万、242.95/10万、247.15/10万、266.85/10万。男性平均发病率为265.82/10万,女性平均发病率为230.38/10万,男性高于女性。40岁及以上年龄组人群发病数占总发病数的91.64%。20岁以下年龄组以白血病多见,20~39岁年龄组以乳腺癌、肝癌、肺癌多见,40岁及以上年龄组以肺癌、肝癌、胃癌多见。恶性肿瘤发病率前5位分别为肺癌、肝癌、胃癌、结直肠癌、乳腺癌,占总发病数的56.74%。结论 2012—2015年乐清市恶性肿瘤发病趋势基本平稳,发病率处于较高水平且呈现逐年缓慢上升趋势,其中肺癌发病率增长最为明显。男性发病率高于女性。40岁以后恶性肿瘤发病率明显升高,需要有针对性地加强健康教育,做好早期监测,降低恶性肿瘤发病率。
Objective To analyze the incidence and epidemic trend of malignant tumors in Yueqing City, Zhejiang Province from 2012 to 2015, and provide evidence for the development of strategies for the prevention and control of malignant tumors. Methods Descriptive epidemiological analysis of the incidence of malignant tumors in Yueqing from 2012 to 2015 was conducted. Results The average annual incidence of malignant tumors in Yueqing City from 2012 to 2015 was 248.85 / 100 000, the annual incidence was 238.24 / 100000, 242.95 / 100000, 247.15 / 100000, 266.85 / 100000 respectively. The average incidence of men was 265.82 / 100000, the average incidence of women was 230.38 / 100000, men than women. The number of people aged 40 and above accounted for 91.64% of the total number of cases. More common in leukemia patients under age 20, breast cancer, liver cancer and lung cancer are common in 20-39 age group. Lung cancer, liver cancer and gastric cancer are common in people aged 40 and over. The top 5 malignant tumors were lung cancer, liver cancer, gastric cancer, colorectal cancer and breast cancer, accounting for 56.74% of the total. Conclusion The incidence of malignant tumors in Yueqing City from 2012 to 2015 was basically stable, the incidence was at a high level and showed a slowly increasing trend year by year, of which the incidence of lung cancer was the most obvious. The incidence of males is higher than that of females. After the age of 40, the incidence of malignant tumors was significantly increased, requiring targeted health education, early monitoring and reduce the incidence of malignant tumors.